mlsanityData to 14 Oct 2026

Vision-Based Assessment of Parkinsonism and Levodopa-Induced Dyskinesia with Deep Learning Pose Estimation

arXiv 1707.09416 ↗First posted 25 Jul 2017cs.CV cs.LGcited by 7

Not on the map. Why?

Abstract (arXiv)

Objective: To apply deep learning pose estimation algorithms for vision-based assessment of parkinsonism and levodopa-induced dyskinesia (LID). Methods: Nine participants with Parkinson's disease (PD) and LID completed a levodopa infusion protocol, where symptoms were assessed at regular intervals using the Unified Dyskinesia Rating Scale (UDysRS) and Unified Parkinson's Disease Rating Scale (UPDRS). A state-of-the-art deep learning pose estimation method was used to extract movement trajectories from videos of PD assessments. Features of the movement trajectories were used to detect and estimate the severity of parkinsonism and LID using random forest. Communication and drinking tasks were used to assess LID, while leg agility and toe tapping tasks were used to assess parkinsonism. Feature sets from tasks were also combined to predict total UDysRS and UPDRS Part III scores. Results: For LID, the communication task yielded the best results for dyskinesia (severity estimation: r = 0.661, detection: AUC = 0.930). For parkinsonism, leg agility had better results for severity estimation (r = 0.618), while toe tapping was better for detection (AUC = 0.773). UDysRS and UPDRS Part III scores were predicted with r = 0.741 and 0.530, respectively. Conclusion: This paper presents the first application of deep learning for vision-based assessment of parkinsonism and LID and demonstrates promising performance for the future translation of deep learning to PD clinical practices. Significance: The proposed system provides insight into the potential of computer vision and deep learning for clinical application in PD.

Key facts. Cited by 7 papers in the map (data through 14 Oct 2026). First posted on arXiv 25 Jul 2017.

Builds on

No reference list yet.

Built on by

Cited by year (2026 to 14 Oct)

Citing papers per year: 2021: 1; 2022: 1; 2023: 1; 2024: 3; 2025: 0; 2026: 1.

7 papers.